Trial Profile
Efficacy and safety study of patients treated with ponatinib in real world clinical practices: A Gelmc study
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Ponatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Expanded access; Therapeutic Use
- Acronyms Gelmc
- 31 Aug 2016 New trial record